- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01141985
New Disposable Contact Lens Patient Interface For The Lensx Laser
Evaluation Of A New Disposable Contact Lens Patient Interface For The Lensx Laser In Cataract And Corneal Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This will be a prospective, single center clinical trial of up to 300 consecutive eyes of subjects scheduled to undergo ocular surgery requiring an initial incision, specifically, cataract surgery. Subjects will be screened for eligibility. Eligible subjects will be examined preoperatively to establish a baseline for ocular condition.
Subjects will undergo unilateral cataract surgery using the LenSx Laser for one or a combination of the following laser procedures: anterior capsulotomy, laser lens phacofragmentation and corneal incision with implantation of an intraocular lens (IOL). Surgeon and staff comments will be solicited for ergonomic and packaging features of the new disposable contact lens. Subjects will be evaluated intraoperatively to assess comfort of the new disposable contact lens, as well as the completion of anterior capsulotomy, laser lens phacofragmentation and completion of corneal incisions. All patients will be evaluated postoperatively at one day, one week and 1 month to follow the condition of the surgical eye. Further follow up can be performed at the discretion of the surgeon.
Study Type
Enrollment (Actual)
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77027
- Slade and Baker Vision Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects must be eligible to undergo cataract extraction by phacoemulsification with primary intraocular lens implantation in at least 1 eye.
- Subjects must be at least 24 years of age.
- Subjects must be willing and able to return for scheduled follow-up examinations.
- Subjects must sign and be given a copy of the written Informed Consent form.
Exclusion Criteria:
- Subjects with corneal disease or pathology that precludes applanation of the cornea or transmission of laser wavelength or distortion of laser light are excluded.
- Subjects with a poorly dilating pupil or other defect of the pupil that prevents the iris from adequate retraction peripherally are excluded.
- Subjects with residual, recurrent, active ocular or eyelid disease, including any corneal abnormality (for example, recurrent corneal erosion, severe basement membrane disease) in either eye are excluded.
- Subjects with a history of steroid-responsive rise in intraocular pressure, glaucoma, or preoperative IOP>21 mm Hg in either eye are excluded.
- Subjects with known lens/zonular instability such as, but not restricted to, Marfan's Syndrome, Pseudoexfoliation Syndrome, etc.
- Subjects who have undergone previous intraocular or corneal surgery of any kind, including any type of surgery for either refractive or therapeutic purposes in either eye are excluded.
- Subjects who are pregnant, lactating, or planning to be pregnant during the course of the study are excluded.
- Subjects with known sensitivity to planned study concomitant medications are excluded.
- Subjects participating in any other ophthalmic drug or device clinical trial during the time of this clinical investigation are excluded
- Subjects presenting any contraindications to cataract surgery are excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Treated
This is a single arm study.
|
Modified Disposable Contact Lens Patient Interface: Like the current disposable contact lens, a single unit is used for each procedure only once, and is then discarded.
It is similarly mounted onto the distal end of the system's focusing objective and serves as a sterile barrier between the patient and the laser.
In place of a separate suction ring that is used in the current contact lens, the modified contact lens has an integrated suction ring and curved applanation surface.
These features result in significantly lower elevation of intraocular pressure and significantly easier application by the surgeon in preliminary testing.
Identical to the current contact lens, the suction ring is applied around the patient's limbus and mild suction is applied to stabilize the eye.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Disposable contact lens successfully applied to the eye
Time Frame: Intraoperative (Day 0)
|
Was the Contact Lens successfully applied to the eye?
Yes or No.
|
Intraoperative (Day 0)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Surgical evaluation of Corneal Incision
Time Frame: Intraoperative (Day 0)
|
Was the corneal incision complete?
|
Intraoperative (Day 0)
|
|
Standard Outcomes Measurements
Time Frame: Pre-operative (Day -60 to Day -1)
|
Standard measurements of Visual Acuity, Manifest Refraction, Slit Lamp Examination, Fundus Examination, Intraocular pressure, Complications and Adverse Events
|
Pre-operative (Day -60 to Day -1)
|
|
Surgical evaluation of capsulotomy
Time Frame: Intraoperative (Day 0)
|
Was capsulotomy complete?
Yes or No.
|
Intraoperative (Day 0)
|
|
Surgical evaluation of fragmentation
Time Frame: Intraoperative (Day 0)
|
Was lens fragmentation complete?
Yes or No.
|
Intraoperative (Day 0)
|
|
Standard outcomes measurement
Time Frame: 1 week (5 to 10 days post operative)
|
Standard measurements of Visual Acuity, Manifest Refraction, Slit Lamp Examination, Fundus Examination, Intraocular pressure, Complications and Adverse Events
|
1 week (5 to 10 days post operative)
|
|
Standard outcomes measurement
Time Frame: 1 day (24 to 48 hours postoperative)
|
Standard measurements of Visual Acuity, Manifest Refraction, Slit Lamp Examination, Fundus Examination, Intraocular pressure, Complications and Adverse Events
|
1 day (24 to 48 hours postoperative)
|
|
Standard outcomes measurement
Time Frame: 1 month (21 to 42 days postoperative)
|
Standard measurements of Visual Acuity, Manifest Refraction, Slit Lamp Examination, Fundus Examination, Intraocular pressure, Complications and Adverse Events
|
1 month (21 to 42 days postoperative)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stephen Slade, MD, Slade and Baker Vision Center
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CPT-001h
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Colvard Kandavel Eye CenterEnrolling by invitationCataract | Cataract Bilateral | Cataract Surgery | Cataract (Post-operative Cataract Surgery Follow-up)United States
-
Matthew RauenNot yet recruitingNuclear Cataract | Cataract Surgery Anesthesia | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Stanford UniversityEnrolling by invitationIntraocular Lens | Cataract Extraction | Cataract Surgery | Eye Disorders | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Züleyha SönmezAtaturk UniversityActive, not recruitingCataract Surgery | Cataract Patients | Cataract After SurgeryTurkey (Türkiye)
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Seva Canada SocietyPragyaan Sustainable Health Outcomes Foundation; Sadgura Netra ChikitsalayaNot yet recruitingCataract (Post-operative Cataract Surgery Follow-up)
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Nicole Fram M.D.RecruitingCataract Bilateral | Nuclear Sclerosis of the Lens | Phacoemulsification Cataract SurgeryUnited States
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Centre hospitalier de l'Université de Montréal...Not yet recruitingCataract | Cataract Bilateral | Cataract Surgery
Clinical Trials on LenSx Laser modified disposable contact lens
-
CooperVision, Inc.CompletedMyopiaUnited States
-
Bausch & Lomb IncorporatedCompleted
-
CooperVision, Inc.Centre for Ocular Research & Education, CanadaCompleted
-
Ohio State UniversityAlcon ResearchCompleted
-
CooperVision, Inc.Completed
-
University of ValenciaWrocław University of Science and TechnologyCompletedTear Film Hyperosmolarity
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed